Non-HACEK Gram-Negative Bacillus Endocarditis

@article{Morpeth2007NonHACEKGB,
  title={Non-HACEK Gram-Negative Bacillus Endocarditis},
  author={Susan Morpeth and David L. Murdoch and Christopher H. Cabell and Adolf W. Karchmer and Paul A. Pappas and Donald P Levine and Francisco Nacinovich and Pierre Tattevin and Nria Fernndez-Hidalgo and Stuart Dickerman and Emilio Bouza and Ana del Ro and Tatjana Lejko-Zupanc and Auristela de Oliveira Ramos and Diana Iarussi and John L. Klein and Catherine Chirouze and Roger Bedimo and Gillian Corey and Vance G. Fowler},
  journal={Annals of Internal Medicine},
  year={2007},
  volume={147},
  pages={829-835}
}
Context Infective endocarditis due to non-HACEK organisms has been considered to be associated with injection drug use. Contribution Analysis of 2761 cases of patients with infective endocarditis from an international collaborative of 61 hospitals found that non-HACEK organisms account for fewer than 2% of the cases, and that most patients with non-HACEK endocarditis had infections associated with health care. Of patients with non-HACEK infections, 59% had implanted endovascular devices or… 
Infective endocarditis caused by gram-negative bacteria
TLDR
Gram-negative bacteria rarely cause infective endocarditis but during selection of empiric therapy in patients with IE with corresponding risk factors, probability of Gram-negative causative microorganisms in IE etiology should be taken into account.
Endocarditis from Klebsiella pneumoniae carbapenemase-producing: an emerging infection? Two case reports
TLDR
The aim of this paper is raising attention on an old but new threat: endocarditis caused by Klebsiella pneumoniae carbapenemase-producing and its possible treatment.
Epidemiology and outcomes of non-HACEK infective endocarditis in the southeast United States
TLDR
Patients who received fluoroquinolone-based IE combination therapy more frequently developed poor outcomes than those who did not, and long-term mortality and readmission rates were high.
Infective endocarditis
TLDR
New strategies to preventfective endocarditis must be explored—including improvement of dental hygiene, decontamination of carriers of Staphylococcus aureus, vaccination, and, possibly, antiplatelet therapy—must be explored.
Endocarditis infecciosa de válvula aórtica por pseudomonas aeruginosa: reporte de caso
TLDR
The case of an immunocompetent 73 year male patient, who had infective endocarditis of an aortic prosthetic valve is described.
Endocarditis infecciosa y embolia séptica pulmonar por Pseudomonas aeruginosa en un paciente con VIH/SIDA
TLDR
The case of a 43-year-old male who presented with lung cavitation consistent with septic embolization in the context of infective endocarditis of the pulmonary valve and Pseudomonas aeruginosa bacteremia is described, with a positive clinical and echocardiographic response to antibiotic therapy.
An unusual etiology of infective endocarditis: Enterobacter cloacae
TLDR
A case of Enterobacter endocarditis is presented in a patient with no prior history of valvular heart disease, implanted endovascular device, or intravenous drug abuse and the patient was treated successfully with carbapenem monotherapy.
A Rare Presentation of Infective Endocarditis Due to Serratia marcescens
TLDR
A patient with S. marcescens bacteremia in a patient with risk factors should prompt further investigation with a thorough evaluation of source followed by immediate management, as this case highlights the fastidious nature of S. Marcescens.
Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents
TLDR
A case of IE caused by Bordetella holmesii is reported in a patient affected by systemic lupus erythematous (SLE) and receiving an immunosuppressive treatment with azathioprine and prednisone, which is a rare and poorly understood disease.
...
...

References

SHOWING 1-10 OF 34 REFERENCES
[Gram negative bacilli endocarditis ].
TLDR
It is concluded that surgery is usually necessary but after an effective antibiotic therapy over a 4 or 6 week period, and more frequent when cardiac sufficiency was present.
Symposium on infective endocarditis. III. Endocarditis due to gram-negative bacteria. Report of 56 cases.
TLDR
There is an increasing incidence of gram-negative bacterial endocarditis and an improving cure rate, compared with past data.
Symposium on infective endocarditis. III. Endocarditis due to gram-negative bacteria. Report of 56 cases.
TLDR
There is an increasing incidence of gram-negative bacterial endocarditis and an improving cure rate 82%, compared with past data.
Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse.
TLDR
From 1969 to 1974, 19 cases of Serratia marcescens endocarditis were observed in the San Francisco Bay Area, and Serratian strains were nonpigmented and had typical antibiotic sensitivities, except that 9 of the isolates exhibited colonial variation.
Left‐Sided Endocarditis due to Pseudomonas aeruginosa: A REPORT OF 10 CASES AND REVIEW OF THE LITERATURE
TLDR
The authors' experience with a high frequency of major vessel embolization and the improved survival after medical/surgical treatment suggests that prompt valve replacement combined with high doses of an aminoglycoside plus carbenicillin or ticarcillin provide the best opportunity for successful outcome in patients with left-sided endocarditis due to P. aeruginosa.
Serratia endocarditis. A follow-up report.
TLDR
The isolation of the same Serratia strain from two patients and their shared injection paraphernalia provided insight into the pathogenesis of endocarditis in the intravenous drug user.
Nonvalvular cardiovascular device-related infections.
  • L. Baddour, M. Bettmann, K. Taubert
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2004
Staphylococcus aureus endocarditis: a consequence of medical progress.
TLDR
Characteristics of patients with S aureus IE vary significantly by region, and further studies are required to determine the causes of regional variation.
Characteristics of left-sided endocarditis due to Pseudomonas aeruginosa in the Detroit Medical Center.
TLDR
The present data suggest that early valve replacement accompanied by a 6-week course of high doses of a combination of drugs may be the optimal therapy for left-sided pseudomonal endocarditis.
...
...